Leiden, The Netherlands — Dutch biotech MIMETAS B.V. announces that it has raised 5.2 million dollar to fund its expansion as a global leader in organ-on-a-chip technology. Venture capital investors Zeeuws Investerings Fonds (ZIF) and Participatiemaatschapij Oost Nederland (PPM Oost) have joined forces with national and regional partners to fund development and sales of MIMETAS’ […]

Qbic Arkiv Fund, Foundation Majoie and SOFI invest 2.0 million EUR in UGent spin-off Biogazelle, a company that offers software and laboratory services for gene expression analysis. Biogazelle will primarily use the investment to further develop its research on therapeutic RNA targets for specific cancer types, and to expand its commercial activities. Biogazelle (www.biogazelle.com) was […]

ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT:BTX) today announced that it has agreed to sell up to an aggregate of 9,431,398 common shares, in a registered direct offering at an offering price of $3.12 per share. The price per share was the closing price of our common shares on the NYSE MKT on October 2, […]

New York, N.Y. — The NASDAQ OMX Group, Inc. (Nasdaq: NDAQ) announced that VWR Corporation (Nasdaq: VWR), a leading, independent provider of laboratory products, services and solutions, commenced trading on The Nasdaq Stock Market on October 2, 2014. VWR enables science in laboratory and production facilities in the pharmaceutical, biotechnology, industrial, education, government and healthcare […]

STEMCELL Technologies has received $949,500 in repayable assistance from the Western Innovation (WINN) Initiative for an exciting project to develop tools and assays for three-dimensional (3D) cell culture. Led by Dr. Steven Woodside, Director of Particle Chemistry and Engineering, and Dr. Eric Jervis, Principal Scientist, the project builds on STEMCELL Technologies’ extensive experience in developing […]

Madison, WI — The National Cancer Institutes has awarded a $1.75M Small Business Innovative Research (SBIR) contract to BellBrook Labs for a collaborative effort with researchers at the University of Wisconsin-Madison to develop more realistic models for breast and ovarian cancer. The research will use imaging and microfabrication technology developed by the UW team to […]

North Brunswick, NJ, USA — Hurel Corporation (“Hurel”), a world-leading provider of in vitro liver models and microfluidic assay platforms that improve the predictive reliability of pre-clinical drug development, today announced that Johnston Associates, Inc. of Princeton, New Jersey (“JAI”) has become a participating investor in the Company’s Series A-3 Preferred Stock financing. Hurel’s lead […]